Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma
Clinical trial NCT02421185 · COMPLETED
Trial details
- NCT number
- NCT02421185
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-25
- Primary completion
- 2019-05-13
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.